Splanchnic concentrations and postprandial release of visceral adipokines

Metabolism: Clinical and Experimental

Volumn 59, Issue 5, 2010, Pages 664-670

  Wiest, Reiner ^a   Moleda, Lukas ^a   Farkas, Stefan ^a   Scherer, Markus ^a   Kopp, Andrea ^a   Wönckhaus, Ulrike ^a   Büchler, Christa ^a   Schölmerich, Jürgen ^a   Schäffler, Andreas ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN;

ADULT; ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTERIOVENOUS SHUNT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; FEMALE; HEPATIC VEIN; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PERIPHERAL VEIN; PORTAL VEIN; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SPLANCHNIC BLOOD FLOW; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION; VENOUS BLOOD; VISCERA;

ADIPOKINES; ADIPONECTIN; ANIMALS; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATIC VEINS; HUMANS; INTRA-ABDOMINAL FAT; LEPTIN; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PORTAL VEIN; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN; SPLANCHNIC CIRCULATION; STATISTICS, NONPARAMETRIC;

EID: 77950603344     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.09.011     Document Type: Article

References (18)

1. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
2. Koerner A., Kratzsch J., and Kiess W. Adipocytokines: leptin-the classical, resistin-the controversial, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19 (2005) 525-546
3. Scherer P.E., Williams S., Fogliano M., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 (1995) 26746-26749
4. Pang S.S., and Le Y.Y. Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 3 (2006) 29-34
5. Moschen A.R., Kaser A., Enrich B., et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178 (2007) 1748-1758
6. Lam Q.L., and Lu L.W. Role of leptin in immunity. Cell Mol Immunol 4 (2007) 1-13
7. Otero M., Lago R., Lago F., et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 579 (2005) 295-301
8. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 (2006) 1537-1545
9. Fontana L., Eagon J.C., Trujillo M.E., et al. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 56 (2007) 1010-1013
10. Taksali S.E., Caprio S., Dziura J., et al. High visceral and low abdominal subcutaneous fat stores in the obese adolescent: a determinant of an adverse metabolic phenotype. Diabetes 57 (2008) 367-371
11. Schaffler A., Scholmerich J., and Buchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2 (2005) 273-280
12. Sommer G., Garten A., Petzold S., et al. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 115 (2008) 13-23
13. Rossle M., Haag K., Ochs A., et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330 (1994) 165-171
14. Nolte W., Wirtz M., Rossbach C., et al. TIPS implantation raises leptin levels in patients with liver cirrhosis. Exp Clin Endocrinol Diabetes 111 (2003) 435-442
15. Bahr M.J., Ockenga J., Boker K.H., et al. Elevated resistin levels in cirrhosis are associated with the proinflammatory state and altered hepatic glucose metabolism but not with insulin resistance. Am J Physiol Endocrinol Metab 291 (2006) E199-E206
16. Kakizaki S., Sohara N., Yamazaki Y., et al. Elevated plasma resistin concentrations in patients with liver cirrhosis. J Gastroenterol Hepatol 23 (2008) 73-77
17. de Boer J.F., Bahr M.J., Boker K.H., et al. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol 296 (2009) G196-201
18. Patel L., Buckels A.C., Kinghorn I.J., et al. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300 (2003) 472-476